Our findings show that IgA levels are higher in naturally infected COVID-19 patients compared to Pfizer and Sinopharm vaccinees and random individuals, indicating that IgA response is more prominent due to natural infections consistent with previous investigations [27, 28]. This evidence concerns the gene CD79A and COVID-19.